How digital education improves HER2‑low awareness in metastatic breast cancer, according to a new Labcorp study

A Labcorp‑led study shows digital education can close HER2‑low knowledge gaps and empower patients with metastatic breast cancer to discuss testing and care options.

Unlocking the science: Hereditary cancer genetic testing in cancer care

Hereditary cancer testing is one of our most powerful tools in the fight against cancer. It enables early detection, personalized treatment decisions, informed surgical decisions, and proactive prevention strategies for patients and their families. Clinical guidelines increasingly support broader use of hereditary cancer testing, and it is becoming more commonly used in clinical practice.